Handelsbanken Fonder Ab Amneal Pharmaceuticals, Inc. Transaction History
Handelsbanken Fonder Ab
- $24.3 Billion
- Q1 2025
A detailed history of Handelsbanken Fonder Ab transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Handelsbanken Fonder Ab holds 39,000 shares of AMRX stock, worth $327,990. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39,000
Previous 39,000
-0.0%
Holding current value
$327,990
Previous $309,000
5.83%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding AMRX
# of Institutions
245Shares Held
136MCall Options Held
302KPut Options Held
103K-
Vanguard Group Inc Valley Forge, PA15.8MShares$133 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$104 Million3.16% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$94.9 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$90.3 Million2.58% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il7.49MShares$63 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.27B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...